|
AstraZeneca Pharma India Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
21822.50 Cr.
|
P/BV
|
32.12
|
Book Value (Rs.)
|
271.74
|
|
52 Week High/Low (Rs.)
|
9211/4800
|
FV/ML
|
2/1
|
P/E(X)
|
135.12
|
|
Bookclosure
|
05/07/2024
|
EPS (Rs.)
|
64.60
|
Div Yield (%)
|
0.27
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 64.60 | 39.70 | 24.60 | 37.30 | 28.90 |
| Diluted EPS (Rs.) | 64.60 | 39.70 | 24.60 | 37.30 | 28.90 |
| Cash EPS (Rs.) | 70.58 | 46.22 | 31.42 | 45.37 | 36.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 284.77 | 235.48 | 204.56 | 182.47 | 145.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 284.77 | 235.48 | 204.56 | 182.47 | 145.78 |
| Dividend / Share (Rs.) | 24.00 | 16.00 | 10.00 | 2.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 518.21 | 401.19 | 322.24 | 325.42 | 332.72 |
| PBDIT / Share (Rs.) | 87.70 | 76.49 | 40.38 | 59.32 | 53.48 |
| PBIT / Share (Rs.) | 81.72 | 69.98 | 33.60 | 51.27 | 46.04 |
| PBT / Share (Rs.) | 87.82 | 53.64 | 33.22 | 50.84 | 45.59 |
| Net Profit / Share (Rs.) | 64.60 | 39.72 | 24.64 | 37.32 | 28.88 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 16.92 | 19.06 | 12.52 | 18.22 | 16.07 |
| PBIT Margin (%) | 15.77 | 17.44 | 10.42 | 15.75 | 13.83 |
| PBT Margin (%) | 16.94 | 13.37 | 10.30 | 15.62 | 13.70 |
| Net Profit Margin (%) | 12.46 | 9.89 | 7.64 | 11.46 | 8.68 |
| Return on Networth / Equity (%) | 22.68 | 16.86 | 12.04 | 20.45 | 19.81 |
| Return on Capital Employeed (%) | 28.34 | 29.11 | 16.03 | 27.20 | 30.36 |
| Return On Assets (%) | 14.98 | 10.08 | 7.19 | 12.04 | 10.22 |
| Asset Turnover Ratio (%) | 1.26 | 1.09 | 0.98 | 1.10 | 1.31 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.61 | 2.18 | 2.12 | 2.04 | 1.66 |
| Quick Ratio (X) | 1.97 | 1.68 | 1.70 | 1.51 | 1.15 |
| Inventory Turnover Ratio (X) | 0.61 | 0.51 | 0.59 | 0.59 | 0.49 |
| Dividend Payout Ratio (NP) (%) | 24.76 | 20.14 | 8.11 | 5.35 | 3.46 |
| Dividend Payout Ratio (CP) (%) | 22.66 | 17.30 | 6.36 | 4.40 | 2.75 |
| Earning Retention Ratio (%) | 75.24 | 79.86 | 91.89 | 94.65 | 96.54 |
| Cash Earning Retention Ratio (%) | 77.34 | 82.70 | 93.64 | 95.60 | 97.25 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 182.71 | 303.52 | 106.25 | 136.06 | 117.27 |
| Interest Coverage Ratio (Post Tax) (%) | 121.90 | 222.46 | 65.84 | 86.60 | 64.34 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 12795.16 | 7617.77 | 5940.17 | 7173.15 | 5726.36 |
| EV / Net Operating Revenue (X) | 9.88 | 7.60 | 7.37 | 8.82 | 6.88 |
| EV / EBITDA (X) | 58.36 | 39.84 | 58.85 | 48.37 | 42.83 |
| MarketCap / Net Operating Revenue (X) | 10.27 | 8.09 | 7.93 | 9.25 | 7.19 |
| Retention Ratios (%) | 75.23 | 79.85 | 91.88 | 94.64 | 96.53 |
| Price / BV (X) | 18.68 | 13.79 | 12.49 | 16.50 | 16.41 |
| Price / Net Operating Revenue (X) | 10.27 | 8.09 | 7.93 | 9.25 | 7.19 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
